Comparison of the clinical and prognostic characteristics of patients with different pathological types in acromegaly

Comparison of the clinical and prognostic characteristics of patients with different pathological types in acromegaly

ContextAcromegaly is caused by somatotroph tumors. Recently, the WHO recommended the use of transcription factors (TFs) together with pituitary hormones to accurately classify the subtypes.ObjectiveThis study aims to evaluate differences in the clinical and prognostic characteristics of acromegaly p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liye Chong, Yuxing Lou, Xue Chen, Wenji Zhao, Wei Zhang, Ziwei Zhang, Fan Yang, Ping Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Endocrinology
Subjects:	acromegaly PIT1/SF1 tumor GH/PRL positive tumor clinical characteristics prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1571598/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Somatic GNAS mutations in acromegaly: prevalence, clinical features and gender differences
by: Yamei Yang, et al.
Published: (2024-12-01)

Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly
by: Jowita Halupczok-Żyła, et al.
Published: (2024-12-01)

The effect of acromegaly on thyroid disease
by: Caiyan Mo, et al.
Published: (2023-11-01)

A single-center prospective study evaluating the relationship of tumor consistency on remission in acromegaly patients
by: Eren Yilmaz, et al.
Published: (2025-01-01)

Changes in retinal microvasculature and serum Gremlin-1 levels in acromegaly: A case-control study
by: Gokcen Unal Kocabas, et al.
Published: (2024-12-01)

Duhok acromegaly; a prospective cohort study
by: Bayar Ahmed Qasim
Published: (2023-03-01)

Clinical Profile and Treatment Outcomes in Patient with Acromegaly Using 14th Acromegaly Consensus Criteria
by: Jyoti Sharma, et al.
Published: (2025-03-01)

Clinical and biochemical characteristics of patients with acromegaly and normal or increased prolactin levels
by: Yuliya A. Kukushkina, et al.
Published: (2024-12-01)

Transcription factor-based classification of pituitary adenomas / PitNETs: a comparative analysis and clinical implications across WHO 2004, 2017 and 2022 in 921 cases
by: Isabella Nasi-Kordhishti, et al.
Published: (2025-06-01)

Evaluation of the activity of arginase and some biochemical parameters in sera of patients with acromegaly
by: Fatima Khazaal Malek, et al.
Published: (2024-12-01)

Recurrent Pericarditis in a Woman With Acromegaly Responding Favorably to Transsphenoidal Surgery
by: Samantha Jacobson, MSc, et al.
Published: (2025-03-01)

Evaluation of Bone Mineral Densitometry Measurements in Newly Diagnosed Acromegaly Patients
by: Murat Çalapkulu, et al.
Published: (2022-08-01)

Retrosternal Goiter with Acromegaly – An Airway Challenge
by: Mukti Deshpande, et al.
Published: (2024-03-01)

Impact of strict IGF1 control on quality-of-life scores in patients with acromegaly
by: Chaitanya Gandhi, et al.
Published: (2025-01-01)

Nursing Care of Patient with Acromegaly Disease — Case Report
by: Seçil Erden Melikoğlu, et al.
Published: (2019-06-01)

Assessment of Obesity, Dyslipidemia, Hyperglycemia, and Pro-Inflammatory Cytokines as Cardiovascular Disease Risk Factors in Acromegaly Patients
by: Noor Thair. Tahir, et al.
Published: (2022-10-01)

Acromegaly as a Multisystem Disease – Analysis of Metabolic Complications. Review of Current Literature
by: Daria Anna Krzyżanowska, et al.
Published: (2025-07-01)

Pasireotide-induced hyperglycemia in Cushing’s disease and Acromegaly: A clinical perspective and algorithms proposal
by: Przemysław Witek, et al.
Published: (2024-12-01)

The GhWL1‐GhH1‐GhGA2OX1 Transcriptional Module Regulates Cotton Leaf Morphology
by: Jingjing Zhan, et al.
Published: (2025-05-01)

Fatigue in acromegaly patients: a scoping review
by: Wei Wang, et al.
Published: (2025-07-01)

Discrepancy between IGF-1 and GH suppression test in follow-up of the treated acromegaly patients
by: Mahshid Naser Langroodi, et al.
Published: (2024-12-01)

Long-Term Results of Cabergoline Add-on Long-Acting Somatostatin Analogue Therapy in Acromegaly Patients
by: Mehmet Muhittin Yalçın, et al.
Published: (2024-10-01)

Differential diagnosis of rheumatic manifestations of acromegaly. Case report
by: Margarita A. Perepelova, et al.
Published: (2024-12-01)

The role of Cytomegalovirus Infection in Diabetic Acromegaly Patients
by: Sarah Abulmahdi Zaghir1, et al.
Published: (2024-09-01)

Evaluating the Fibroblast Growth Factor-23 and Phosphate in Iraqi Patients with Acromegaly
by: Sara A. Kashash, et al.
Published: (2024-03-01)

Knowledge and attitudes of primary care physicians regarding acromegaly: a survey study with multinational participation
by: Aysen Kutan Fenercioglu, et al.
Published: (2024-12-01)

Genome-wide identification and analysis of GH1-containing H1 histones among poplar species
by: Ping Li, et al.
Published: (2025-03-01)

Advances in the Oral Administration of Somatostatin Receptor Ligands in Acromegaly: A Systematic Review Focusing on Biochemical Response
by: Clémence Reverdiau, et al.
Published: (2024-10-01)

Short- and long-term glycemic effects of pasireotide in patients with acromegaly: a comprehensive case study with review of literature
by: Yuki Taki, et al.
Published: (2025-04-01)

Cost-effectiveness analysis of second-line medical therapies in acromegaly: a real-life study
by: Eva Venegas Moreno, et al.
Published: (2025-04-01)

Corrigendum: Biomarkers of GH deficiency identified in untreated and GH-treated Pit-1 mutant mice
by: Sarmed Al-Samerria, et al.
Published: (2025-08-01)

Biomarkers of GH deficiency identified in untreated and GH-treated Pit-1 mutant mice
by: Sarmed Al-Samerria, et al.
Published: (2025-04-01)

Abnormal expression of Hippo–YAP1 signalling pathway and progesterone resistance mechanism in endometrial polyps
by: Xinyu Yu, et al.
Published: (2025-12-01)

Features of carbohydrate metabolism and incretin secretion in patients with Cushing disease and acromegaly
by: Lubov V. Matchekhina, et al.
Published: (2017-10-01)

The Role of Soluble α-klotho Protein in Acromegaly
by: Oana PINZARIU, et al.
Published: (2023-03-01)

Cocaine‐Induced Apoplexy of a GH‐Secreting Pituitary Tumor
by: Dalia Cuenca, et al.
Published: (2025-05-01)

Multi-omics study reveals gut microbiota dysbiosis and tryptophan metabolism alterations in GH-PitNET progression
by: Jifang Liu, et al.
Published: (2025-07-01)

Acromegaly in Speckle Tracking Echocardiography—A New Cardiac Hypertrophy Phenotype? Case Report and Review
by: Alexander Suchodolski, et al.
Published: (2024-11-01)

Hyperostosis frontalis interna and association of disease control with frontal bone thickness in acromegaly
by: Ihsan Ayhan, et al.
Published: (2025-03-01)

Pituitary Neuroendocrine Tumors (PitNETs) – a literature review
by: Jakub Skiba, et al.
Published: (2024-11-01)